Children in most deprived areas more likely to visit A&E and be obese
In the report published on Monday, every local authority in England was analysed against its level of deprivation and a range of early childhood health and educational outcomes.
It found that, when considering early years development, the most deprived authorities were more than twice as far away from achieving the Government's 'good level' target of 75% than the most affluent areas.
Only four of the 151 upper tier local authorities in England are currently meeting that target.
Nearly twice as many children suffer from late-stage, untreated tooth decay in the most deprived areas (29%) compared to the least deprived (15%), while five-year-old children living in the poorest communities are three times more likely to have had teeth removed due to decay, the report found.
Almost a quarter of reception-age children in the most deprived areas (24%) are overweight or obese, while general obesity levels in those areas are more than double those of children in the most affluent areas (12.9%, compared to 6%).
There is also an average of 1,020 A&E visits per 1,000 babies and young children in the most deprived areas, an increase of 55% on rates in the most affluent areas, the report found.
The five local authorities with the highest levels of deprivation – Blackpool, Knowsley, Liverpool, Kingston upon Hull, and Middlesbrough – were each in the lowest 20% for five of the six child wellbeing measures used in the analysis.
Some 1.2 million babies and children under the age of five – 35% of the age group's total population – now live in poverty across England, the report said.
It added that child poverty has increased more in the UK then in any of the 38 OECD and EU countries.
Among the report's recommendations are long-term, sustainable funding and expanding provision for Family Hubs, recruiting an additional 1,000 health visitors a year and making access to Government-funded childcare hours equal for all children aged two or older, regardless of their location or parental employment.
Unicef UK, joined by BBC presenter Dr Chris Van Tulleken, will present a petition calling for investments in early childhood, which has more than 105,000 signatures, to the Prime Minister at 10 Downing Street on Tuesday.
Chief executive Dr Philip Goodwin warned the consequences of growing up in poverty can be lifelong and said the report's findings were 'not acceptable'.
He said: 'There must be immediate, decisive, and ambitious action by the government. Any further delays will entrench inequality and condemn hundreds of thousands of children to poverty and its effects, as child poverty rates continue to rise.
'The Government must act urgently to lift the two-child limit and the benefit cap and commit to investing in the vital health and education services that support children during their crucial early years.'
Introduced in 2015 by then-Conservative chancellor George Osborne, the cap restricts child welfare payments to the first two children born to most families.
Sir Keir Starmer said he was 'absolutely determined' to 'drive down' child poverty when he was pressed on the two-child benefit cap in Parliament last week, ahead of the publication of the Government's strategy on the issue.
Try Our AI Features
Explore what Daily8 AI can do for you:
Comments
No comments yet...
Related Articles
Daily Mirror
21 hours ago
- Daily Mirror
Tesco UK boss: 'Price alone won't help customers to shop a healthier basket'
Ashwin Prasad, the chief executive of Tesco's UK arm, writes: 'We, and the whole food industry, can and must innovate and find new ways to encourage healthier choices' Good health starts with good food. We all know the importance of getting a balanced diet – for our health, and the health of those we care about. But worryingly, the latest data shows many of us aren't getting the nutritious diet we need. Fewer than one in five adults and one in 10 children regularly eat the recommended five-a-day. That needs to change. Getting enough fruit and veg can reduce the risk of longer-term health conditions, like heart disease, stroke, and some types of cancer. As the Government's new food strategy rightly identifies, the more people we can help to eat their five-a-day, the more people we can help to live healthier lives. That means we need to listen and understand the barriers people face to getting their five-a-day. Over the last year, we have been working with the British Nutrition Foundation to understand in more detail the challenges our customers face when it comes to eating healthily. We spent time in communities up and down the UK, speaking to community members, including youth and charity workers, council members, and health professionals. Affordability is of course front of mind for many. But it's clear that price alone won't help customers to shop a healthier basket. We want to help our customers make small changes that amount to big health benefits for themselves and their families. People told us they want help with ideas and inspiration, or need more confidence in cooking healthy meals. And they want to see young people empowered to make healthier choices through access to fruit and veg and education. We, and the whole food industry, can and must innovate and find new ways to encourage healthier choices, so we can put healthy food in the hands of customers, more of the time. That's why at Tesco we are launching a campaign to help families eat their five-a-day. We are investing in new initiatives to inspire and incentivise our customers to make healthier choices easier for everyone. That includes new personalised Clubcard Stamps for millions of customers on fruit and veg that will be tailored to their buying habits, Clubcard Challenges on frozen and tinned fruit and veg and pulses, additional Clubcard prices and offers in store, and refreshed recipe inspiration online. That's on top of long-running promotions on fruit and veg, like Fresh 5, and two thirds of our Aldi Price Match products being healthy. We'll also be building out our support for kids to get off to a healthy start in life. As well as providing millions of pieces of fruit and vegetables to thousands of children in 400 schools across the UK this year through our Fruit & Veg for Schools programme, we'll be giving away free fruit for kids in selected stores across the UK during the school holidays. We're committed to doing our part, now and in future – but we won't solve this alone. It's time for the whole food industry to come together with the Government and wider society so that great nutrition is something everyone can enjoy. As Health and Social Care Secretary Wes Streeting says: "Obesity has doubled since the 1990s and costs our NHS £11 billion a year, triple the budget for ambulance services. Unless we curb the rising tide of cost and demand, the NHS risks becoming unsustainable. The good news is that it only takes a small change to make a big difference. If everyone who is overweight reduced their calorie intake by around 200 calories a day - the equivalent of a bottle of fizzy drink - obesity would be halved. This government's ambition for kids today is for them to be part of the healthiest generation of children ever. That is within our grasp. With the smart steps we're taking today, we can give every child a healthy start to life. "Our brilliant supermarkets already do so much work for our communities and are trying to make their stores heathier, and we want to work with them and other businesses to create a level playing field. Through our new healthy food standard, we will make the healthy choice the easy choice, because prevention is better than cure. By shifting from sickness to prevention through our Plan for Change, we will make sure the NHS can be there for us when we need it." Only through collective and co-ordinated action across the whole of the food industry can we make an impact at scale. Doing so will not only help millions of families to live healthier lives. It will also boost our economy, reduce the number of people living with long-term health conditions linked to poor diet, and relieve pressure on our health services. The Government's plans to mandate food businesses to report on healthy food sales and take action to increase them are a positive step. We look forward to working with them on the details of the Healthy Food Standard and its implementation by all relevant food businesses to create a truly level playing field. We're committed to playing our part, working with the wider food industry and our health charity partners. We've shown what's possible when we work together as an industry. Through further collaboration and innovation, we can work to put healthy choices into the hands of customers, wherever they live, more of the time.
Reuters
a day ago
- Reuters
Sarepta fails to win EU backing for muscle disorder gene therapy
July 25 (Reuters) - Sarepta Therapeutics (SRPT.O), opens new tab failed to win the European drug regulator's backing for its muscle disorder gene therapy on Friday, as the company faces intense regulatory scrutiny after two recent patient deaths tied to the treatment. Shares of the Cambridge, Massachusetts-based company slumped 11%. They have lost 88.8% so far this year. The EU committee's negative opinion for Elevidys is yet another major setback for the company, which was directed by the U.S. health regulator earlier this month to stop all shipments of the gene therapy — the only one approved by it for treating Duchenne muscular dystrophy (DMD). Sarepta had already halted dosing in non-ambulatory patients, meaning those unable to walk independently, and later complied with the U.S. Food and Drug Administration's request to pause all shipments, along with Roche (ROG.S), opens new tab — its partner outside the U.S. "While we are disappointed by CHMP's (Committee for Medicinal Products for Human Use) negative opinion, we understand the urgent need for continued dialogue and collaboration to bring transformative therapies to people with Duchenne," said Sarepta's research and development head, Louise Rodino-Klapac. DMD is primarily seen in males, affecting 1 in 5,000 boys born worldwide. The average life expectancy for someone with the disorder is 22 years. William Blair analyst Sami Corwin said the fall in Sarepta shares reflected the reduced revenue from potential future milestone and royalty payments from Roche. "While we believe there is a possibility the pause on Elevidys shipments in the U.S. is lifted before year-end specifically for young and ambulatory patients... the uncertainty will continue to pressure stock." Roche said on Friday it would continue its dialogue with the European Medicines Agency to explore a potential path forward to make Elevidys available in the EU. The benefit-risk profile remains positive in the ambulatory patients, the Swiss drugmaker said. Sarepta said it continues to work with the FDA in the U.S. to address recent safety concerns related to Elevidys.
The Independent
a day ago
- The Independent
EU regulator approves injectable HIV drug that experts say could help stop transmission
The European Medicines Agency has recommended authorizing a twice-yearly injectable drug aimed at preventing HIV, which scientists say could help end the virus' transmission. In a statement on Friday, the EU drug regulator said its evaluations of lenacapavir, sold as Yeytuo in Europe by Gilead Sciences, showed the drug is 'highly effective' and 'considered to be of major public health interest.' Once the regulator's guidance is accepted by the European Commission, the authorization is valid in all 27 EU member countries as well as Iceland, Norway and Liechtenstein. Last year, studies suggested that lenacapavir, already used to treat people with HIV, was nearly 100% effective in stopping transmission in both women and men. Winnie Byanyima, executive director of the U.N. AIDS agency, has said the drug 'could change the trajectory of the HIV epidemic' if it is made available to everyone who needs it. In June, the U.S. Food and Drug Administration authorized lenacapavir to prevent HIV. Earlier this month, the World Health Organization recommended countries offer the drug as an additional option to people at risk of the virus. Condoms help guard against HIV infection if used properly. Other medication aimed at preventing HIV include daily pills that people can take and another injectable drug called cabotegravir, which is given every two months. Lenacapavir's six-month protection makes it the longest-lasting type, an option that could attract people wary of more visits to health clinics or stigma from taking daily pills. Critics have raised concerns, however, that lenacapavir may not be made widely enough available to stop global outbreaks of HIV. Drugmaker Gilead has said it will allow cheap, generic versions to be sold in 120 poor countries with high HIV rates — mostly in Africa, Southeast Asia and the Caribbean. But it has excluded nearly all of Latin America, where rates are far lower but increasing, sparking concern the world is missing a critical opportunity to stop the disease. Last year, there were about 630,000 AIDS deaths worldwide and more than 40 million people are estimated to have HIV, according to UNAIDS. UNAIDS chief Byanyima has previously suggested the U.S. President Donald Trump make a deal with Gilead to produce and license its 'magical' prevention drug lenacapavir across the world to the millions of people who need it. ___ The Associated Press Health and Science Department receives support from the Howard Hughes Medical Institute's Department of Science Education and the Robert Wood Johnson Foundation. The AP is solely responsible for all content.
